CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? Long-term Variations of FFR and iFR After Transcatheter Aortic Valve Implantation Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year Outcome

Clinical Trial4 Apr 2022

JOURNAL:Circulation. Article Link

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial

D-W Park, J-M Ahn, D-Y Kang et al. Keywords: TAVR; without an indication for long-term anticoagulation; subclinical leaflet thrombosis

Full Text PDF